Panbela Therapeutics Inc. (PBLA)
0.36
-0.00 (-0.03%)
At close: Mar 03, 2025, 9:42 AM
Panbela Therapeutics Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| PE Ratio | -0.00 | -0.04 | -2 | -5.77 | -3.86 | -55.27 | -68.73 | -122.76 | -57.66 | -271.74 | -137.19 | 117.58 | -210.31 |
| PEG Ratio | -0.00 | -0.00 | -0.05 | 0.13 | -0.00 | 0.98 | -0.89 | 2.31 | -0.16 | 5.49 | 0.74 | -0.42 | n/a |
| PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 21.44 | 29.87 | 23.60 | 41.57 |
| PB Ratio | -0.00 | -0.19 | 1.98 | 3.26 | 17.29 | 1.22K | -193.29 | -135.19 | -105.97 | -137.88 | -210.95 | -712.12 | -71.82 |
| P/FCF Ratio | -0.00 | -0.09 | -3.02 | -7.14 | -8.74 | -136.72 | -209.59 | -261.71 | -72.9 | -2.54K | -718.13 | 783.77 | -352.29 |
| P/OCF Ratio | -0.00 | -0.1 | -3.02 | -7.14 | -8.74 | -136.72 | -209.59 | -261.71 | -72.9 | -2.54K | -821.93 | 783.77 | -398.24 |
| OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.01 | -0.04 | 0.03 | -0.1 |
| Debt / Equity Ratio | -1.1 | -0.85 | n/a | n/a | 0.08 | 1.31 | -0.49 | -0.71 | -1.24 | -2.73 | -4.22 | -14.35 | -1.4 |
| Quick Ratio | 0.25 | 0.23 | 4.62 | 7.15 | 1.76 | 1.13 | 0.18 | 0.16 | 1.26 | 0.64 | 0.65 | 0.52 | 0.37 |
| Current Ratio | 0.25 | 0.23 | 4.62 | 7.15 | 1.76 | 1.13 | 0.18 | 0.16 | 1.26 | 0.64 | 0.65 | 0.52 | 0.37 |
| Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.33 | 1.83 | 2.02 | 2.76 |
| Interest Coverage | 161.81 | -118.38 | -910 | -338.47 | -1.97 | -2.14 | -3.72 | -28.71 | -29.75 | -2.12 | -5.41 | 7.82 | -3.05 |
| Return on Equity (ROE) | 5.36 | 4.34 | -0.99 | -0.56 | -4.48 | -22.03 | 2.81 | 1.10 | 1.84 | 0.51 | 1.54 | -6.06 | 0.34 |
| Return on Assets (ROA) | -2.14 | -7.02 | -0.79 | -0.49 | -1.97 | -3.11 | -13.53 | -5.83 | -2.73 | -0.26 | -0.4 | 0.40 | -0.54 |
| Return on Capital (ROIC) | 99.41 | 11.94 | -0.98 | -0.68 | -3.12 | -14.52 | 1.77 | 1.11 | -12.57 | 0.36 | 1.48 | -8.68 | 0.26 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 56.14% | 42.65% | 43.88% | 21.32% |
| Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.89% | -21.77% | 20.07% | -19.77% |
| Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.88% | -21.75% | 20.09% | -19.75% |
| Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.56% | -19.95% | 22.94% | -14.93% |
| FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.84% | -4.16% | 3.01% | -11.8% |
| EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.56% | -19.95% | 23.48% | -14.49% |